EMEA-000410-PIP01-08-M07 - paediatric investigation plan
Regadenoson
PIPHuman
Key facts
- Invented name
- Rapiscan
- Active Substance
- Regadenoson
- Therapeutic area
- Cardiac disorders
- Decision number
- P/0238/2024
- PIP number
- EMEA-000410-PIP01-08-M07
- Pharmaceutical form(s)
- Solution for injection
- Condition(s) / indication(s)
- Diagnosis of myocardial perfusion disturbances
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
GE Healthcare AS
Email: petra.jeevaratnam@gehealthcare.com
Tel. +44 (0)1494 544000- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date